UPM Biomedicals
Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Stay up to date with UPM Biomedicals
Our latest press releases
UPM and Nichirei Biosciences announce partnership to supply Japanese 3D cell culture market with GrowDex® advanced natural hydrogels
(UPM, Helsinki, 13 March 2020 at 09:00 EET) - UPM Biomedicals and Nichirei Biosciences Inc. have signed an agreement on 1 March, 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will...
UPM joins the new consortium to investigate theranostic potential of extracellular vesicles
(UPM, Helsinki, 17 February 2020 at 11:00 EET) UPM has joined a newly formed Finnish research consortium that plans to use extracellular vesicles to develop novel nano-biotechnological solutions for the early diagnostics and treatment of severe...
UPM launches non-animal derived GrowInk™ 3D printing product range at SLAS2020
UPM is entering the exciting world of 3D printing, offering novel non-animal derived, ready-to-use hydrogels which mimic the in vivo environment to support cell growth and differentiation. The new GrowInk™ Bioinks product range is being launched a...
UPM Biomedicals launches GrowDex-T hydrogel with advanced features and further strengthens its leading position in animal free sustainable 3D hydrogel technology
(UPM Biomedicals, Helsinki, 31 July 2019 at 10:00 EET) – UPM launches GrowDex®-T - a new hydrogel offering researchers exceptional imaging properties for visualisation of cells in 3D. GrowDex-T is the latest addition to the UPM Biomedicals’ GrowDe...